{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:11:01Z","timestamp":1791461461300,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,28]]},"DOI":"10.7759\/cureus.33048","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T16:30:28Z","timestamp":1672245028000},"source":"Crossref","is-referenced-by-count":6,"title":["A Case Report and Literature Review of New-Onset Myasthenia Gravis After COVID-19 Infection"],"prefix":"10.7759","author":[{"given":"Tulika","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sriviji","family":"Senthil Kumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moni","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14721","article-title":"Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection","volume":"28","author":"Assini A","year":"2021","unstructured":"Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, Del Sette M. Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. 2021, 28:3537-9. 10.1111\/ene.14721","journal-title":"Eur J Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22717","article-title":"A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications","volume":"324","author":"Datta SD","year":"2020","unstructured":"Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020, 324:2251-2. 10.1001\/jama.2020.22717","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2118","article-title":"Neuropathogenic human coronaviruses: a review","volume":"30","author":"Abdelaziz OS","year":"2020","unstructured":"Abdelaziz OS, Waffa Z. Neuropathogenic human coronaviruses: a review. Rev Med Virol. 2020, 30:e2118. 10.1002\/rmv.2118","journal-title":"Rev Med Virol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084081","article-title":"Neurological complications of COVID-19: underlying mechanisms and management","volume":"22","author":"Shehata GA","year":"2021","unstructured":"Shehata GA, Lord KC, Grudzinski MC, Elsayed M, Abdelnaby R, Elshabrawy HA. Neurological complications of COVID-19: underlying mechanisms and management. Int J Mol Sci. 2021, 22:4081. 10.3390\/ijms22084081","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25973","article-title":"B cells in the pathophysiology of myasthenia gravis","volume":"57","author":"Yi JS","year":"2018","unstructured":"Yi JS, Guptill JT, Stathopoulos P, Nowak RJ, O'Connor KC. B cells in the pathophysiology of myasthenia gravis. Muscle Nerve. 2018, 57:172-84. 10.1002\/mus.25973","journal-title":"Muscle Nerve"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2020.04.062","article-title":"Guillain Barre syndrome associated with COVID-19 infection: a case report","volume":"76","author":"Sedaghat Z","year":"2020","unstructured":"Sedaghat Z, Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci. 2020, 76:233-5. 10.1016\/j.jocn.2020.04.062","journal-title":"J Clin Neurosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2020.e00771","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection","volume":"20","author":"Virani A","year":"2020","unstructured":"Virani A, Rabold E, Hanson T, et al.. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection. IDCases. 2020, 20:e00771. 10.1016\/j.idcr.2020.e00771","journal-title":"IDCases"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30109-5","article-title":"Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?","volume":"19","author":"Zhao H","year":"2020","unstructured":"Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barr\u00e9 syndrome associated with SARS-CoV-2 infection: causality or coincidence?. Lancet Neurol. 2020, 19:383-4. 10.1016\/S1474-4422(20)30109-5","journal-title":"Lancet Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009619","article-title":"Miller Fisher syndrome and polyneuritis cranialis in COVID-19","volume":"95","author":"Guti\u00e9rrez-Ortiz C","year":"2020","unstructured":"Guti\u00e9rrez-Ortiz C, M\u00e9ndez-Guerrero A, Rodrigo-Rey S, et al.. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020, 95:e601-5. 10.1212\/WNL.0000000000009619","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.978","article-title":"New-onset myasthenia gravis after novel coronavirus 2019 infection","volume":"10","author":"Taheri A","year":"2022","unstructured":"Taheri A, Davoodi L, Soleymani E, Ahmadi N. New-onset myasthenia gravis after novel coronavirus 2019 infection. Respirol Case Rep. 2022, 10:e0978. 10.1002\/rcr2.978","journal-title":"Respirol Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.576153","article-title":"Postinfectious onset of myasthenia gravis in a COVID-19 patient","volume":"11","author":"Huber M","year":"2020","unstructured":"Huber M, Rogozinski S, Puppe W, Framme C, H\u00f6glinger G, Hufendiek K, Wegner F. Postinfectious onset of myasthenia gravis in a COVID-19 patient. Front Neurol. 2020, 11:576153. 10.3389\/fneur.2020.576153","journal-title":"Front Neurol"},{"key":"ref12","article-title":"Post-varicella myasthenia gravis","volume":"48","author":"Saha A","year":"2007","unstructured":"Saha A, Batra P, Vilhekar KY, Chaturvedi P. Post-varicella myasthenia gravis. Singapore Med J. 2007, 48:177-80.","journal-title":"Singapore Med J"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27020","article-title":"COVID-19 in muscle-specific kinase myasthenia gravis: a case report","volume":"62","author":"Kushlaf H","year":"2020","unstructured":"Kushlaf H. COVID-19 in muscle-specific kinase myasthenia gravis: a case report. Muscle Nerve. 2020, 62:E65-6. 10.1002\/mus.27020","journal-title":"Muscle Nerve"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.01053","article-title":"Myasthenia gravis and COVID-19: clinical characteristics and outcomes","volume":"11","author":"Camelo-Filho AE","year":"2020","unstructured":"Camelo-Filho AE, Silva AM, Estephan EP, et al.. Myasthenia gravis and COVID-19: clinical characteristics and outcomes. Front Neurol. 2020, 11:1053. 10.3389\/fneur.2020.01053","journal-title":"Front Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26918","article-title":"COVID-19 in patients with myasthenia gravis","volume":"62","author":"Anand P","year":"2020","unstructured":"Anand P, Slama MC, Kaku M, et al.. COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020, 62:254-8. 10.1002\/mus.26918","journal-title":"Muscle Nerve"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8845844","article-title":"COVID-19 presentation in association with myasthenia gravis: a case report and review of the literature","volume":"2020","author":"Aksoy E","year":"2020","unstructured":"Aksoy E, Oztutgan T. COVID-19 presentation in association with myasthenia gravis: a case report and review of the literature. Case Rep Infect Dis. 2020, 2020:8845844. 10.1155\/2020\/8845844","journal-title":"Case Rep Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116888","article-title":"Myasthenic crisis in COVID-19","volume":"414","author":"Delly F","year":"2020","unstructured":"Delly F, Syed MJ, Lisak RP, Zutshi D. Myasthenic crisis in COVID-19. J Neurol Sci. 2020, 414:116888. 10.1016\/j.jns.2020.116888","journal-title":"J Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106045","article-title":"COVID-19 and generalized myasthenia gravis exacerbation: a case report","volume":"196","author":"Singh S","year":"2020","unstructured":"Singh S, Govindarajan R. COVID-19 and generalized myasthenia gravis exacerbation: a case report. Clin Neurol Neurosurg. 2020, 196:106045. 10.1016\/j.clineuro.2020.106045","journal-title":"Clin Neurol Neurosurg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10263-1","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review","volume":"268","author":"Sriwastava S","year":"2021","unstructured":"Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol. 2021, 268:2690-6. 10.1007\/s00415-020-10263-1","journal-title":"J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.30476\/IJMS.2021.89841.2061","article-title":"Manifestation of ocular myasthenia gravis as an initial symptom of coronavirus disease 2019: a case report","volume":"47","author":"Rahimian N","year":"2022","unstructured":"Rahimian N, Alibeik N, Pishgar E, Dini P, Abolmaali M, Mirzaasgari Z. Manifestation of ocular myasthenia gravis as an initial symptom of coronavirus disease 2019: a case report. Iran J Med Sci. 2022, 47:385-8. 10.30476\/IJMS.2021.89841.2061","journal-title":"Iran J Med Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.09.001","article-title":"SARS-CoV-2 vaccination and new-onset myasthenia gravis: a report of 7 cases and review of the literature","volume":"32","author":"Ramdas S","year":"2022","unstructured":"Ramdas S, Hum RM, Price A, et al.. SARS-CoV-2 vaccination and new-onset myasthenia gravis: a report of 7 cases and review of the literature. Neuromuscul Disord. 2022, 32:785-9. 10.1016\/j.nmd.2022.09.001","journal-title":"Neuromuscul Disord"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106834","article-title":"Myasthenia gravis associated with novel coronavirus 2019 infection: a report of three cases","volume":"208","author":"Karimi N","year":"2021","unstructured":"Karimi N, Okhovat AA, Ziaadini B, Haghi Ashtiani B, Nafissi S, Fatehi F. Myasthenia gravis associated with novel coronavirus 2019 infection: a report of three cases. Clin Neurol Neurosurg. 2021, 208:106834. 10.1016\/j.clineuro.2021.106834","journal-title":"Clin Neurol Neurosurg"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2020.04.003","article-title":"SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies","volume":"35","author":"P\u00e9rez \u00c1lvarez \u00c1I","year":"2020","unstructured":"P\u00e9rez \u00c1lvarez \u00c1I, Su\u00e1rez Cuervo C, Fern\u00e1ndez Men\u00e9ndez S. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies. Neurolog\u00eda. 2020, 35:264-5. 10.1016\/j.nrleng.2020.04.003","journal-title":"Neurolog\u00eda"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo DA","year":"2020","unstructured":"Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020, 173:1027-8. 10.7326\/L20-0845","journal-title":"Ann Intern Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2021.105771","article-title":"Management of thymomatous myasthenia gravis - case report of a rare Covid19 infection sequelae","volume":"81","author":"Bhandarwar A","year":"2021","unstructured":"Bhandarwar A, Jadhav S, Tandur A, Dhimole N, Wagh A, Bhondve S. Management of thymomatous myasthenia gravis - case report of a rare Covid19 infection sequelae. Int J Surg Case Rep. 2021, 81:105771. 10.1016\/j.ijscr.2021.105771","journal-title":"Int J Surg Case Rep"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244146","article-title":"Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?","volume":"14","author":"Muralidhar Reddy Y","year":"2021","unstructured":"Muralidhar Reddy Y, B SK, Osman S, Murthy JM. Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?. BMJ Case Rep. 2021, 14:e244146. 10.1136\/bcr-2021-244146","journal-title":"BMJ Case Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.7326\/L20-1298","article-title":"MuSK antibody-associated myasthenia gravis with SARS-CoV-2 infection: a case report","volume":"174","author":"Muhammed L","year":"2021","unstructured":"Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSK antibody-associated myasthenia gravis with SARS-CoV-2 infection: a case report. Ann Intern Med. 2021, 174:872-3. 10.7326\/L20-1298","journal-title":"Ann Intern Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244102","article-title":"Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection","volume":"14","author":"Essajee F","year":"2021","unstructured":"Essajee F, Lishman J, Solomons R, Abraham DR, Goussard P, Van Toorn R. Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection. BMJ Case Rep. 2021, 14:e244102. 10.1136\/bcr-2021-244102","journal-title":"BMJ Case Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante P","year":"2010","unstructured":"Cavalcante P, Serafini B, Rosicarelli B, et al.. Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol. 2010, 67:726-38. 10.1002\/ana.21902","journal-title":"Ann Neurol"},{"key":"ref30","article-title":"Myasthenia gravis associated with dual infection of HIV and HTLV-I","volume":"18","author":"Verma A","year":"1995","unstructured":"Verma A, Berger J. Myasthenia gravis associated with dual infection of HIV and HTLV-I. Muscle Nerve. 1995, 18:1355-6.","journal-title":"Muscle Nerve"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880180819","article-title":"Transient myasthenia gravis during HIV infection","volume":"18","author":"Authier FJ","year":"1995","unstructured":"Authier FJ, De Grissac N, Degos JD, Gherardi RK. Transient myasthenia gravis during HIV infection. Muscle Nerve. 1995, 18:914-6. 10.1002\/mus.880180819","journal-title":"Muscle Nerve"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/08830738050200051501","article-title":"Postinfectious myasthenia gravis: report of two children","volume":"20","author":"Felice KJ","year":"2005","unstructured":"Felice KJ, DiMario FJ, Conway SR. Postinfectious myasthenia gravis: report of two children. J Child Neurol. 2005, 20:441-4. 10.1177\/08830738050200051501","journal-title":"J Child Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23869","article-title":"West nile virus infection and myasthenia gravis","volume":"49","author":"Leis AA","year":"2014","unstructured":"Leis AA, Szatmary G, Ross MA, Stokic DS. West nile virus infection and myasthenia gravis. Muscle Nerve. 2014, 49:26-9. 10.1002\/mus.23869","journal-title":"Muscle Nerve"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul MA","year":"2020","unstructured":"Ellul MA, Benjamin L, Singh B, et al.. Neurological associations of COVID-19. Lancet Neurol. 2020, 19:767-83. 10.1016\/S1474-4422(20)30221-0","journal-title":"Lancet Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198501243120407","article-title":"Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis","volume":"312","author":"Stefansson K","year":"1985","unstructured":"Stefansson K, Dieperink ME, Richman DP, Gomez CM, Marton LS. Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis. N Engl J Med. 1985, 312:221-5. 10.1056\/NEJM198501243120407","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114282","article-title":"Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus","volume":"84","author":"Schwimmbeck PL","year":"1989","unstructured":"Schwimmbeck PL, Dyrberg T, Drachman DB, Oldstone MB. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Invest. 1989, 84:1174-80. 10.1172\/JCI114282","journal-title":"J Clin Invest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000776","article-title":"COVID-19 and autoimmune diseases","volume":"33","author":"Liu Y","year":"2021","unstructured":"Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021, 33:155-62. 10.1097\/BOR.0000000000000776","journal-title":"Curr Opin Rheumatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders DB","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M, et al.. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016, 87:419-25. 10.1212\/WNL.0000000000002790","journal-title":"Neurology"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.1.25","article-title":"Late-onset myasthenia gravis: a changing scene","volume":"56","author":"Aarli JA","year":"1999","unstructured":"Aarli JA. Late-onset myasthenia gravis: a changing scene. Arch Neurol. 1999, 56:25-7. 10.1001\/archneur.56.1.25","journal-title":"Arch Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129412-a-case-report-and-literature-review-of-new-onset-myasthenia-gravis-after-covid-19-infection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:11Z","timestamp":1707508031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129412-a-case-report-and-literature-review-of-new-onset-myasthenia-gravis-after-covid-19-infection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.33048","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,28]]}}}